Cristina Fuss, MD, PhD
she/her/hers
Professor of Radiology and Biomedical ImagingCards
About
Research
Publications
2025
Cardiac Magnetic Resonance Imaging in Immune Checkpoint Inhibitor–Related Myocarditis
Hammer M, Tysarowski M, Fuss C, Bader A. Cardiac Magnetic Resonance Imaging in Immune Checkpoint Inhibitor–Related Myocarditis. Echocardiography 2025, 42: e70131. PMID: 40067334, DOI: 10.1111/echo.70131.Peer-Reviewed Original ResearchConceptsImmune-related adverse eventsImmune checkpoint inhibitorsCardiac magnetic resonance imagingMagnetic resonance imagingAssociated with immune-related adverse eventsCardiac immune-related adverse eventsMechanisms of immune checkpoint inhibitorsICI-associated myocarditisICI-related myocarditisResonance imagingPersonalized cancer immunotherapySevere cardiovascular complicationsImmune tolerance pathwayCheckpoint inhibitorsCancer immunotherapyCardiac complicationsCombination therapyTumor cytotoxicityClinical presentationCardiovascular complicationsAdverse eventsTherapeutic efficacyOncological treatmentTherapeutic strategiesMyocarditisLow-Dose CT of the Chest: Is High-Risk Population Screening for Both Lung Cancer and Cardiovascular Disease Possible?
Fuss C. Low-Dose CT of the Chest: Is High-Risk Population Screening for Both Lung Cancer and Cardiovascular Disease Possible? Radiology 2025, 314: e250215. PMID: 39964272, DOI: 10.1148/radiol.250215.Peer-Reviewed Original Research
2024
CT for Congenital Heart Disease
Fuss C. CT for Congenital Heart Disease. 2024, 277-293. DOI: 10.1007/978-981-97-6919-3_21.Peer-Reviewed Original ResearchCongenital heart diseaseHeart diseaseEvaluation of congenital heart diseaseManagement of congenital heart diseaseContrast doseAffected patientsBirth defectsStages of repairRadiation exposureAltered physiologySmall organ sizeCT roleDiseaseVariable stagesCongenitallyPatientsCTDoseSpatial image resolutionComplexity of defectsBirthImmunological and microbial shifts in the aging rhesus macaque lung during nontuberculous mycobacterial infection
Cinco I, Napier E, Rhoades N, Davies M, Allison D, Kohama S, Bermudez L, Winthrop K, Fuss C, Spindel E, Messaoudi I. Immunological and microbial shifts in the aging rhesus macaque lung during nontuberculous mycobacterial infection. MBio 2024, 15: e00829-24. PMID: 38771046, PMCID: PMC11237422, DOI: 10.1128/mbio.00829-24.Peer-Reviewed Original ResearchConceptsNTM pulmonary diseaseIncreased disease severityNontuberculous mycobacteriaDisease severityBacterial DNAAged animalsAntigen-specific T cellsPulmonary diseaseAssociated with increased disease severityDysregulated macrophage responsePersistence of bacterial DNALack of animal modelsRhesus macaquesSingle-cell RNA sequencingNontuberculous mycobacterial infectionsImmune cell infiltrationRhesus macaque modelBacterial loadAged rhesus macaquesTesting novel therapeuticsRight caudal lobeLower respiratory microbiomeYears of ageMAH infectionMicrobial communitiesTransthoracic Echocardiography–Guided Placement of a Pulmonary Artery Catheter in a Patient With a Known Persistent Left but Unknown Absent Right Superior Vena Cava
Leclerc J, Clemes R, Fuss C, Macon C, Schulman P. Transthoracic Echocardiography–Guided Placement of a Pulmonary Artery Catheter in a Patient With a Known Persistent Left but Unknown Absent Right Superior Vena Cava. Circulation Cardiovascular Imaging 2024, 17: e016301. PMID: 38469718, DOI: 10.1161/circimaging.123.016301.Peer-Reviewed Original Research
2023
Filamin C-associated Cardiomyopathy on Cardiac MR Images.
Weller S, Bartz-Overman C, Fuss C, Wu E. Filamin C-associated Cardiomyopathy on Cardiac MR Images. Radiology Cardiothoracic Imaging 2023, 5: e230165. PMID: 38166338, PMCID: PMC11163239, DOI: 10.1148/ryct.230165.Peer-Reviewed Original ResearchImaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination.
Sánchez Tijmes F, Marschner C, de Matos J, Urzua Fresno C, Gutiérrez Chacoff J, Thavendiranathan P, Fuss C, Hanneman K. Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination. RadioGraphics 2023, 43: e230044. PMID: 37616171, DOI: 10.1148/rg.230044.Peer-Reviewed Original ResearchConceptsLate gadolinium enhancementGadolinium enhancementCardiac MRICOVID-19 vaccinePattern of late gadolinium enhancementCardiac complications of COVID-19MRNA-based COVID-19 vaccinesPresence of cardiovascular diseaseStress-induced cardiomyopathyMultimodality cardiac imagingBasal inferolateral wallMinority of patientsPersistent cardiac symptomsAdverse cardiovascular eventsComplications of COVID-19Chronic cardiac complicationsManifestations of COVID-19Potential mechanisms of injuryMechanism of injuryCardiovascular manifestations of COVID-19Messenger ribonucleic acidAcute COVID-19Cardiac symptomsCardiovascular manifestationsImaging findingsStandardized medical terminology for cardiac computed tomography 2023 update- commentary by North American Society of Cardiovascular Imaging (NASCI)
Rai A, Allen B, Fuss C, Dennie C, Hanneman K. Standardized medical terminology for cardiac computed tomography 2023 update- commentary by North American Society of Cardiovascular Imaging (NASCI). The International Journal Of Cardiovascular Imaging 2023, 39: 2255-2257. PMID: 37589871, DOI: 10.1007/s10554-023-02922-x.Peer-Reviewed Original ResearchOpen-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease
Siegel S, Griffith D, Philley J, Brown-Elliott B, Brunton A, Sullivan P, Fuss C, Strnad L, Wallace R, Winthrop K. Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease. CHEST Journal 2023, 164: 846-859. PMID: 37419144, PMCID: PMC10645596, DOI: 10.1016/j.chest.2023.05.036.Peer-Reviewed Original ResearchConceptsAmikacin liposome inhalation suspensionAmikacin resistanceCulture conversionInhalation suspensionMycobacterium abscessus lung diseasePresence of macrolide resistanceEnd pointsMicrobiological end pointsMonthly sputum culturesSputum culture conversionTreatment-refractory diseaseOpen-label protocolSecondary end pointsOpen-label trialCohort of patientsCavitary diseaseSputum culturePretreatment isolatesM abscessusOpen-labelOral antimicrobialsParenteral antibioticsCompanion therapyMacrolide resistanceMultidrug therapyThe updated CADS-RADS 2.0: Changes, challenges and considerations for implementation—commentary by North American Society of Cardiovascular Imaging (NASCI)
Johannesen J, Hanneman K, Fuss C, Truong Q. The updated CADS-RADS 2.0: Changes, challenges and considerations for implementation—commentary by North American Society of Cardiovascular Imaging (NASCI). The International Journal Of Cardiovascular Imaging 2023, 39: 465-467. PMID: 36652039, DOI: 10.1007/s10554-023-02795-0.Peer-Reviewed Original Research
Clinical Care
Overview
Cristina Fuss, MD, PhD, a radiologist specializing in cardiothoracic imaging, focuses on the use of advanced imaging techniques to diagnose and manage conditions affecting the heart and lungs.
As a professor of radiology and biomedical imaging at Yale School of Medicine, Dr. Fuss is actively involved in research aimed at improving imaging techniques for better patient outcomes. Her work is dedicated to enhancing the accuracy and effectiveness of diagnostic imaging in cardiothoracic care.
Dr. Fuss earned her medical and doctoral degrees from the University of Heidelberg in Germany, where she also pursued residency training in diagnostic radiology. She later completed a fellowship in cardiothoracic imaging at Oregon Health & Science University.
Clinical Specialties
Radiology & Biomedical Imaging
News
Get In Touch
Contacts
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.